Nkarta, Inc.

Nkarta, Inc.verified

NKTX

Price:

$1.84

Market Cap:

$130.69M

Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the surface of tumor cells. Its two co-lead product candidates are NKX101, which is in Phase I clinical trials for the treatment of relapsed/refractory acute myeloid leukemia or higher risk myelodysplastic syndromes; and NKX019, a pre-clinical product, which is based on the ability to treat various B cell malignancies by targeting the CD19 antigen found on t...[Read more]

Industry

Biotechnology

IPO Date

2020-07-10

Stock Exchange

NASDAQ

Ticker

NKTX

The Enterprise Value as of December 2025 (TTM) for Nkarta, Inc. (NKTX) is 155.82M

According to Nkarta, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 155.82M. This represents a change of -31.27% compared to the average of 226.72M of the last 4 quarters.

Nkarta, Inc. (NKTX) Historical Enterprise Value (quarterly & annually)

How has NKTX Enterprise Value performed in the past?

The mean historical Enterprise Value of Nkarta, Inc. over the last ten years is 866.53M. The current 155.82M Enterprise Value has changed 1.70% with respect to the historical average. Over the past ten years (40 quarters), NKTX's Enterprise Value was at its highest in in the December 2020 quarter at 1.92B. The Enterprise Value was at its lowest in in the June 2019 quarter at 0.

Quarterly (TTM)
Annual

Average

866.53M

Median

416.99M

Minimum

221.38M

Maximum

2.41B

Nkarta, Inc. (NKTX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Nkarta, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 347.68%

Maximum Annual Enterprise Value = 2.41B

Minimum Annual Increase = -82.72%

Minimum Annual Enterprise Value = 221.38M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2024221.38M-41.86%
2023380.79M22.42%
2022311.04M-31.79%
2021456.00M-75.57%
20201.87B347.68%
2019416.99M-82.72%

Nkarta, Inc. (NKTX) Average Enterprise Value

How has NKTX Enterprise Value performed in the past?

The current Enterprise Value of Nkarta, Inc. (NKTX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

304.41M

5-year avg

647.20M

10-year avg

866.53M

Nkarta, Inc. (NKTX) Enterprise Value vs. Peers

How is NKTX’s Enterprise Value compared to its peers?

Nkarta, Inc.’s Enterprise Value is greater than Alector, Inc. (82.63M), less than PepGen Inc. (347.79M), less than Fate Therapeutics, Inc. (165.48M), greater than Molecular Partners AG (45.15M), greater than Cassava Sciences, Inc. (48.00M), greater than Applied Therapeutics, Inc. (23.64M), greater than Cybin Inc. (63.89M), greater than Elicio Therapeutics, Inc. (128.40M), greater than Vor Biopharma Inc. (-100309963.00), less than Forte Biosciences, Inc. (164.14M),

CompanyEnterprise ValueMarket cap
82.63M$121.26M
347.79M$365.00M
165.48M$126.86M
45.15M$168.84M
48.00M$160.38M
23.64M$33.09M
63.89M$296.80M
128.40M$143.68M
-100309963.00$57.09M
164.14M$257.55M

Build a custom stock screener for Nkarta, Inc. (NKTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Nkarta, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Nkarta, Inc. (NKTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Nkarta, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Nkarta, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Nkarta, Inc. (NKTX)?

What is the 3-year average Enterprise Value for Nkarta, Inc. (NKTX)?

What is the 5-year average Enterprise Value for Nkarta, Inc. (NKTX)?

How does the current Enterprise Value for Nkarta, Inc. (NKTX) compare to its historical average?